Thomas McEachin - 12 Aug 2026 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Reporting relationship: Director
Issuer ticker: MD
Reported as of: 12 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Aug 2026, 17:00:17 UTC
Prior SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ David Haddock, Attorney-in-Fact

Key filing fact

Thomas McEachin filed Form 4 for Pediatrix Medical Group, Inc. (MD) on 14 Aug 2026.

Key facts

This page summarizes Thomas McEachin's Form 4 filing for Pediatrix Medical Group, Inc. (MD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Aug 2026, 17:00.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001659781 Primary reporting owner

McEachin Thomas

Relationship: Director
Address: 1301 CONCORD TERRACE, SUNRISE
Signature: /s/ David Haddock, Attorney-in-Fact
Signature date: 14 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MD transaction

Common Stock

Award

Transaction value
Shares: +472
Change %: +6.6%
Price: $26.50^*
Shares after: 7,668
Date: 12 Aug 2026
Ownership: Direct
Footnotes: F1

MD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 66,073
Date: 12 Aug 2026
Ownership: Thomas A. McEachin Living Trust dated April 17, 2025.
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Footnote F2

The reporting person and his spouse are trustees and beneficiaries of the trust that holds the reported securities.